Is Caribou Biosciences, Inc. (CRBU) a Buy, Sell, or Hold?
NASDAQ : CRBU
Caribou Biosciences, Inc. — Institutional Ownership
$1.65 USD
$0.01 (0.61%)
- Volume
- 802.06K
- Average Volume
- 1.99M
- Market Capitalization
- $163.65M
- P/E Ratio
- -1.16
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.54
- Year Low
- $1.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.22
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-27 | BlackRock, Inc. | 7.18M | 7.20% |
| 2025-07-16 | BlackRock, Inc. | 1.84M | 2.00% |
| 2025-04-30 | The Vanguard Group | 4.52M | 4.86% |
| 2025-04-25 | Rachel E. Haurwitz | 4.72M | 5.00% |
| 2025-04-25 | Felix Adler | 4.72M | 5.00% |
| 2025-04-25 | The City Canyon Family Trust dated May 31, 2021 | 3.37M | 3.60% |
| 2025-04-17 | BlackRock, Inc. | 6.28M | 6.80% |
| 2025-02-14 | BANK OF AMERICA CORP /DE/ | 1.95M | 2.20% |
| 2024-11-14 | BANK OF AMERICA CORP /DE/56-0906609 | 5.05M | 5.60% |
| 2024-02-23 | Steven A. Cohen | 4.43M | 5.00% |
| 2024-02-23 | Point72 Asset Management, L.P. | 3.96M | 4.50% |
| 2024-02-23 | Point72 Capital Advisors, Inc. | 3.96M | 4.50% |
| 2024-02-23 | 72 Investment Holdings, LLC | 474.07K | 0.50% |
| 2024-02-23 | Point72 Biotech Private Investments, LLC | 474.07K | 0.50% |
| 2024-02-23 | Differentiated Ventures Investments, LLC | 474.07K | 0.50% |
| 2024-01-08 | David Witzke | 6.36M | 7.20% |
| 2024-01-08 | Avidity Capital Partners (GP) LLC | 6.36M | 7.20% |
| 2024-01-08 | Avidity Capital Partners Fund (GP) LP | 6.36M | 7.20% |
| 2024-01-08 | Avidity Partners Management LP | 6.36M | 7.20% |
| 2024-01-08 | Michael Gregory | 6.36M | 7.20% |
| 2024-01-08 | Avidity Master Fund LP | 4.69M | 5.30% |
| 2024-01-08 | Avidity Partners Management (GP) LLC | 6.36M | 7.20% |
| 2023-07-20 | 2 | 474.07K | 0.60% |
| 2023-07-20 | 2 | 474.07K | 0.60% |
| 2023-07-20 | 2 | 474.07K | 0.60% |
| 2023-07-20 | 2 | 4.09M | 5.10% |
| 2023-07-20 | 2 | 3.61M | 4.50% |
| 2023-07-20 | 2 | 3.61M | 4.50% |
| 2023-07-20 | 2 | 738.0 | 12.00% |
| 2023-07-10 | PFIZER INC. | 4.69M | 7.10% |
| 2023-02-03 | (1) BlackRock, Inc. | 4.72M | 7.70% |
| 2023-02-03 | STATE STREET CORPORATION | 3.2M | 5.24% |
| 2022-06-01 | E. I. du Pont de Nemours and Company | 2.06M | 3.39% |
| 2022-03-01 | E. I. du Pont de Nemours and Company | 3.15M | 5.24% |
| 2022-02-11 | Thomas G. Roberts, Jr. | 2.96M | 4.90% |
| 2022-02-11 | Zone III Healthcare Holdings, LLC | 2.43M | 4.00% |
| 2022-02-11 | Farallon Capital Partners, L.P. | 66600.0 | 0.10% |
| 2022-02-11 | Farallon Capital Institutional Partners, L.P. | 157.2K | 0.30% |
| 2022-02-11 | Farallon Capital Institutional Partners II, L.P. | 25600.0 | 0.00% |
| 2022-02-11 | Farallon Capital Institutional Partners III, L.P. | 14300.0 | 0.00% |
| 2022-02-11 | Four Crossings Institutional Partners V, L.P. | 18900.0 | 0.00% |
| 2022-02-11 | Farallon Capital Offshore Investors II, L.P. | 209.2K | 0.30% |
| 2022-02-11 | Farallon Capital F5 Master I, L.P. | 36000.0 | 0.10% |
| 2022-02-11 | Farallon Capital (AM) Investors, L.P. | 7500.0 | 0.00% |
| 2022-02-11 | Farallon Capital Management, L.L.C. | 2.43M | 4.00% |
| 2022-02-11 | Farallon Partners, L.L.C. | 499.3K | 0.80% |
| 2022-02-11 | Farallon Institutional (GP) V, L.L.C. | 18900.0 | 0.00% |
| 2022-02-11 | Farallon F5 (GP), L.L.C. | 36000.0 | 0.10% |
| 2022-02-11 | David T. Kim | 2.96M | 4.90% |
| 2022-02-11 | Michael G. Linn | 2.96M | 4.90% |
| 2022-02-11 | Rajiv A. Patel | 2.96M | 4.90% |
| 2022-02-11 | William Seybold | 2.96M | 4.90% |
| 2022-02-11 | Andrew J. M. Spokes | 2.96M | 4.90% |
| 2022-02-11 | John R. Warren | 2.96M | 4.90% |
| 2022-02-11 | Mark C. Wehrly | 2.96M | 4.90% |
| 2022-02-11 | Philip D. Dreyfuss | 2.96M | 4.90% |
| 2022-02-11 | Michael B. Fisch | 2.96M | 4.90% |
| 2022-02-11 | Richard B. Fried | 2.96M | 4.90% |
| 2021-08-06 | PFM Health Sciences, LP | 6.0 | 7.20% |
| 2021-08-03 | II, L.P. | 305.35K | 0.50% |
| 2021-08-03 | Partners V, L.P. | 27700.0 | 0.00% |
| 2021-08-03 | Partners III, L.P. | 20900.0 | 0.00% |
| 2021-08-03 | Farallon Capital Partners, L.P. | 97100.0 | 0.20% |
| 2021-08-03 | L.P. | 10800.0 | 0.00% |
| 2021-08-03 | Richard B. Fried | 3.36M | 5.90% |
| 2021-08-03 | David T. Kim | 3.36M | 5.90% |
| 2021-08-03 | Michael G. Linn | 3.36M | 5.90% |
| 2021-08-03 | Rajiv A. Patel | 3.36M | 5.90% |
| 2021-08-03 | Thomas G. Roberts, Jr. | 3.36M | 5.90% |
| 2021-08-03 | William Seybold | 3.36M | 5.90% |
| 2021-08-03 | L.L.C. | 2.58M | 4.50% |
| 2021-08-03 | L.P. | 52300.0 | 0.10% |
| 2021-08-03 | Farallon Partners, L.L.C. | 728.95K | 1.30% |
| 2021-08-03 | John R. Warren | 3.36M | 5.90% |
| 2021-08-03 | Mark C. Wehrly | 3.36M | 5.90% |
| 2021-08-03 | Partners II, L.P. | 37400.0 | 0.10% |
| 2021-08-03 | Partners, L.P. | 229.7K | 0.40% |
| 2021-08-03 | Andrew J. M. Spokes | 3.36M | 5.90% |
| 2021-08-03 | LLC | 2.58M | 4.50% |
| 2021-08-03 | L.L.C. | 27700.0 | 0.00% |
| 2021-08-03 | Farallon F5 (GP), L.L.C. | 52300.0 | 0.10% |
| 2021-08-03 | Philip D. Dreyfuss | 3.36M | 5.90% |
| 2021-08-03 | Michael B. Fisch | 3.36M | 5.90% |
| 2021-07-29 | FMR LLC | 3.32M | 5.86% |
| 2021-07-29 | Abigail P. Johnson | 3.32M | 5.86% |
| 2019-01-16 | Biosciences, Inc. | 2.51M | 5.80% |
| 2019-01-16 | Therapeutics Holdco, LLC | 2.51M | 5.80% |
| 2018-02-06 | Therapeutics Holdco, LLC | 4.54M | 10.70% |
| 2018-02-06 | Biosciences, Inc. | 4.54M | 10.70% |
| 2017-02-28 | Biosciences, Inc. | 5.59M | 15.50% |
| 2017-02-28 | Therapeutics Holdco, LLC | 5.59M | 15.50% |
CRBU Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.59 | 93.39M | $148.49M | $12.36M | $27.23M | $163.36M |
| 2024-12-31 | $1.59 | 90.32M | $143.61M | $16.29M | $26.49M | $153.8M |
| 2023-12-31 | $5.73 | 73.81M | $422.92M | $51.16M | $27.11M | $398.86M |
| 2022-12-31 | $6.28 | 60.8M | $381.83M | $58.34M | $27.75M | $351.24M |
| 2021-12-31 | $15.09 | 60.26M | $909.37M | $240.42M | $259K | $669.21M |
| 2020-12-31 | $16.32 | 27.66M | $451.37M | $15.95M | $1.58M | $436.99M |
| 2019-12-31 | $16.32 | 27.66M | $451.37M | $41.07M | $532K | $410.83M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.90 | 95.86M | $182.14M | $12.06M | $26.95M | $197.03M |
| 2025-12-31 | $1.59 | 94.54M | $150.31M | $12.36M | $27.23M | $165.18M |
| 2025-09-30 | $2.33 | 93.29M | $217.37M | $11.14M | $25.46M | $231.69M |
| 2025-06-30 | $1.26 | 93.03M | $117.22M | $25.2M | $25.85M | $117.87M |
| 2025-03-31 | $0.91 | 92.68M | $84.63M | $29.42M | $26.22M | $81.43M |
| 2024-12-31 | $1.59 | 90.32M | $143.61M | $16.29M | $26.49M | $153.8M |
| 2024-09-30 | $1.96 | 90.46M | $177.29M | $31.97M | $27.84M | $173.16M |
| 2024-06-30 | $1.59 | 90.34M | $143.64M | $37.87M | $28.59M | $134.37M |
| 2024-03-31 | $5.05 | 89.3M | $450.98M | $49.4M | $28.85M | $430.43M |
| 2023-12-31 | $5.73 | 88.43M | $506.72M | $51.16M | $27.11M | $482.67M |
| 2023-09-30 | $4.78 | 83.78M | $400.49M | $104.06M | $27.46M | $323.88M |
| 2023-06-30 | $4.25 | 61.42M | $261.03M | $66.19M | $27.23M | $222.07M |